Republicans, Democrats Clash in Congress on Drug Pricing

Partisan Squabbles Shadow Congress’ Efforts to Lower Drug Prices

Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke to CNN about partisan disagreements in Congress regarding drug prices.

Republicans have recently accused Democrats of shutting them out of developing legislation. While both sides agree that making generic drugs more available is a top priority, some feel that President Donald Trump’s proposals regarding drug pricing don’t fall in line with typical Republican stances on the matter.

Spatz said he is surprised by the ongoing conflict in Congress.

“The political dynamic we are seeing today is unprecedented,” he said. Spatz also said there is “a Republican in the White House who has made drug prices an important agenda item, but he’s taking positions that are not traditionally Republican.”

Read the article here



pursuant to New York DR 2-101(f)

© 2020 Manatt, Phelps & Phillips, LLP.

All rights reserved